Market Overview

Pfizer Rallies Off Allergan News

Related PFE
Analyst: Is The Street Ignoring Pfizer And Its Upcoming Catalysts?
Lightning Round: Jim Cramer Is A Seller Of Pandora, Lost Faith In Chipotle
Your Daily Pharma Scoop: Gilead CAR-T Potential, Egalet Surges, Aerie Launches Mid-Stage Study (Seeking Alpha)

Pfizer (NYSE: PFE) shares are trading higher by $0.88 at $31.60 in Tuesday's session. The Street is applauding a possible cancellation of its merger with Allergan (NYSE: AGN) due to the tax inversion news. Pfizer's last statement said it's conducting review of Department of Treasury's actions.

In a volatile session, the issue has found support just under Monday's close ($30.72), reaching $30.58 and rallying firmly into the $31 handle. It is now approaching its January 8 high of $31.63. There may be additional resistance at the pair of highs from January 6 ($31.90) and January 7 ($431.81).

Posted-In: Technicals Intraday Update Movers Trading Ideas


Related Articles (AGN + PFE)

View Comments and Join the Discussion!

Partner Center